Director, CHIEF EXECUTIVE OFFICER · Travere Therapeutics, Inc. · Travere Therapeutics, Inc. — Employee stock option (right to buy)
Side
M
Value
—
Shares
43.7K
Price
—
Executed
Oct 15, 2026
Disclosed
Oct 19, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Oct 15 executedOct 19, 2026 disclosed
TVTX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 34.9% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 6 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Travere Therapeutics, Inc. — Employee stock option (right to buy)
Ticker
TVTX
Shares
43.7K
Price per share
$0
Execution date (reported)
Oct 15, 2026
Owned after transaction
168.9K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
4
What this establishes
Dube Eric M filed this Form 4 reporting a option exercise of TVTX on Oct 15, 2026. It became public on Oct 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CHIEF EXECUTIVE OFFICER
Dube Eric Mcik:0001763494
Issuer
Travere Therapeutics, Inc.cik:0001438533
Revision history · 0
No field has changed since this record was first ingested.
